<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Archives of Asthma, Allergy and Immunology</title>
<link>https://www.theskygallerypattaya.com/haard</link>
<description>A Heighpubs Open Access Journal</description>
<language>en-us</language>
	<item>
		<title>Immunological background for treatments with biologicals in CRSwNP</title>
		<pubDate>04/08/2021</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1026.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Background: Chronic rhinosinusitis (CRS) is a heterogeneous and multifactorial inflammatory disease of the nasal and paranasal mucosa. To date, no internationally standardized uniform classification has been developed for this disease.&amp;lt;br /&amp;gt;
Usually, a phenotype classification according to CRS with (CRSwNP) and without (CRSsNP) polyposis is performed. However, through a variety of studies, it has been shown that even within these phenotypes, different endotypes of CRS exist, each with a different underlying inflammatory pathophysiology. In this mini-review, we aim to outline the essential immunological processes in CRSwNP and to highlight the modern therapeutic options with biologics derived from this disease.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Methods: Current knowledge on the immunological and molecular processes of CRS, especially CRSwNP, was compiled by means of a structured literature review. Medline, PubMed, national/international trial and guideline registries as well as the Cochrane Library were all searched.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Results: Based on the current literature, the different immunological processes involved in CRS and nasal polyps were elaborated. Current studies on the therapy of eosinophilic diseases such as asthma and polyposis are presented and their results discussed.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Conclusion: Understanding the immunological basis of CRSwNP may help to develop new personalized therapeutic approaches using biologics. Currently, 2 biologics (dupilumab, omalizumab) have been approved for the therapy of CRSwNP (polyposis nasi) in Europe.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Higher venom-specific IgE levels differentiate children with previous local large reactions from children with previous systemic reactions of different severity</title>
		<pubDate>03/19/2021</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1025.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Introduction: Risk factors for systemic reactions (SRs) from hymenoptera venom (HV) allergy are well known in the adult population but they have been little studied in the pediatric one.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Method: The aim of our study was to identify risk factors for SRs in a population of children allergic to HV, comparing a series of clinical (age, gender, atopy, asthma) and laboratory (total IgE, tryptase, venom-specific IgE levels) variables between patients with at least two large local reactions (LLRs) and patients with SRs of different severity for the identified insect. We selected a population of HV allergic children aged &amp;amp;lt; 15 years with LLRs or SRs stratified according to Mueller grades after stinging.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Results: The population included 80 children, 35 with at least 2 LLRs and 45 with SRs. The level of specific IgE for vespid (Polistes dominula, Vespula species) venoms was significantly higher (p = 0.0321) in children with SRs (Mueller grade II+III+IV) than in those with LLRs and the same significance was also found for specific IgE for Apis mellifera, considering SRs group (Mueller grade I+II+III+IV) in respect with LLRs group (p = 0.0001).&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Conclusion: The main difference in our pediatric population was the highest level of specific IgE in children with a history of SRs compared to those with a history of LLRs for both vespids and honey bees. These results, once confirmed on a larger population, could suggest the opportunity to follow the behavior of venom specific IgE in children with LLRs to reveal a risk to develop future more serious reactions.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Cyn d 1 airborne allergen in a Southern Brazilian city</title>
		<pubDate>02/26/2021</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1024.php</link>
		<description>&amp;lt;p&amp;gt;By researching the factors related to exposure to indoor and outdoor allergens, such seasons, climate changes and particulate matter, allergists can screen the sensitization profile of individuals according to their exposures and conduct preventive treatment and individualized immunotherapy.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>A retrospective cohort study to evaluate the relationship of airway hyperresponsiveness to type 2 biomarkers in persistent asthma</title>
		<pubDate>02/17/2021</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1023.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Airway hyperresponsiveness (AHR) is a hallmark of persistent asthma measured using direct or indirect airway bronchial challenge testing. The purpose of this study is to investigate the putative relationships between type 2 inflammatory biomarkers, airway geometry (FEV1 and FEF25-75) and specific IgE (RAST or skin prick) to AHR. We performed a retrospective analysis of our database (n = 131) of patients with asthma. Of these subjects, 75 had a histamine challenge and 56 had a mannitol challenge. Fractional exhaled nitric oxide (FeNO) and specific immunoglobulin E (IgE) but not blood eosinophils were significantly higher in patients with AHR to either histamine or mannitol. FEV1 % and FEF25 - 75 % were significantly lower in patients with AHR. Elevated Type 2 biomarkers including FeNO and specific IgE but not blood eosinophils were associated with AHR.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Highlights: FeNO and specific IgE but not blood eosinophils are raised in patients with airway hyperresponsiveness.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Helping asthmatic children through bonding therapy</title>
		<pubDate>02/05/2021</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1022.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Disruptions in Maternal-infant Bonding are shown to be the mediating variable between maternal distress and the subsequent expression of childhood asthma. When the mothers&amp;amp;rsquo; bonding is repaired, their children&amp;amp;rsquo;s asthmatic symptoms diminish or remit. This study evaluated 16 asthmatic children before and after their mothers were treated with Bonding Therapy. Fourteen improved on 11 measures, including reduction in the STEP classification system and medication use. Thirteen children were able to stop all medications. Surprisingly, all mothers scores on the Beck Depression Inventory improved through Bonding Therapy, suggesting that impaired bonding can lead to maternal depression or even Postpartum Depression. The link between bonding disruptions and airway inflammation are discussed. Bonding Therapy is described.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Cystic fibrosis and congenital adrenal hyperplasia: A rare occurrence with diagnostic dilemmas, similarities and contradictions</title>
		<pubDate>10/20/2020</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1021.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Cystic fibrosis (CF) is a hereditary syndrome composed of exocrine gland dysfunction&amp;amp;nbsp;&amp;amp;nbsp; involving multiple systems which if untreated may result in chronic respiratory infections, pancreatic enzyme deficiency and failure to thrive. The association between CF and other inherited diseases or congenital anomalies is rare. We describe a rare case of CF with concomitant congenital adrenal hyperplasia (CAH). 21- Hydroxylase deficiency accounts for most CAH cases. Varity in clinical phenotypes depends on the amount of enzymatic activity which in turn depends on different combination of gene mutations. The genes of CAH and CF are located in different locations. The chance of these diseases coexisting in our patient would be a rare combination. However, such a case will be more frequent in our population than others because of consanguineous marriage and common ancestors. There are diagnostic difficulties, similarities and contradictions between two diseases and they are pointed out.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Short-term responses to high-dose inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease with a fractional nitric oxide concentration over 35 parts per billion: A single-centre preâ€“post study</title>
		<pubDate>10/06/2020</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1020.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Introduction: There is currently no strategy for identifying chronic obstructive pulmonary disease (COPD) patients whose pulmonary function could benefit from inhaled corticosteroids. We investigated whether a 28-day regime of inhaled corticosteroids improved pulmonary function test results among COPD patients with a fractional exhaled nitric oxide concentration &amp;amp;gt; 35 parts per billion.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Methods: This single-centre one-arm pre&amp;amp;ndash;post trial included COPD patients with a fractional exhaled nitric oxide concentration &amp;amp;gt; 35 parts per billion treated at our institution from September 2018 to August 2019. Patients were administered budesonide (200 &amp;amp;mu;g, 8 puffs daily) for 28 days. The primary outcome measure was the difference between the forced expiratory volume in 1 s (FEV1) at baseline and after 28 days of inhaled corticosteroid treatment. Secondary outcomes included differences in COPD Assessment Test scores, %FEV1, and that between the percent forced vital capacity (%FVC) at baseline and after 28 days of treatment.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Results: Twenty patients completed the 28-day inhaled corticosteroid regime. The mean difference in FEV1 between day 1 and day 28 was 340 mL (95% confidence interval: &amp;amp;minus;100 to 770 mL; p = 0.122). The mean differences in secondary outcomes were: %FVC, &amp;amp;minus;0.16% (95% confidence interval [CI]: &amp;amp;minus;2.84 to 2.53%; p = 0.905); %FEV1, 1.63% (95%CI: &amp;amp;minus;4.56 to 7.81%; p = 0.589); COPD Assessment Test score, &amp;amp;minus;2.50 (95%CI: &amp;amp;minus;5.72 to 0.72; p = 0.121).&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Conclusion: The 28-day course of inhaled corticosteroids yielded no significant difference in FEV1 for COPD patients with a fractional exhaled nitric oxide concentration &amp;amp;gt; 35 parts per billion.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Trial registration: University Hospital Medical Information Network Center, UMIN000034005. Registered 3 September 2018,&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000038557&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>A mild form of Familial Mediterranean Fever associated with a polymorphisms C.NT 1588,-69G></title>
		<pubDate>08/11/2020</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1019.php</link>
		<description>&amp;lt;p&amp;gt;Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease caused by mutation(s) in the Mediterranean fever (MEFV, pyrinmarenostrin) gene [1,2].&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Immune system and quality of life following aerobic exercise versus resistance exercise training among Alzheimerâ€™s</title>
		<pubDate>04/30/2020</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1018.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Background:&amp;lt;/strong&amp;gt; Globally, Alzheimer&amp;amp;rsquo;s disease (AD) affects millions of elderly individuals are affected with AD who suffer from decline in cognitive ability. However, immune system dysfunction has a role in AD pathogenesis. However, pharmacological therapeutic intervention for caring of ADis not available. Therefore there is a need to develop novel therapeutic modalities for AD individual care.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Objective:&amp;lt;/strong&amp;gt; The objective of the this trial was to detect immune system and quality of life (QOL) response following aerobic versus resisted exercise training among AD subjects.&amp;amp;nbsp;&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Methods:&amp;lt;/strong&amp;gt; Fifty older with AD disease the range of age ranged was 61 to 73 years enrolled in the current study. However, smoking, liver, chest, renal, metabolic and cardiac dysfunction considered as exclusion criteria. Participants were randomly enrolled into group (A) who applied aerobic exercise intervention, while group (B) applied resisted exercise intervention for period of six months.&amp;amp;nbsp;&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Results:&amp;lt;/strong&amp;gt; The SF-36 which measure QOL along with in the immunological parameters (CD3 count, CD4 count, CD8 count and CD4/CD8 ratio) showed significant improvement following aerobic and resisted exercise. However, comparing between both groups showed significant differences with greater significant improvement in all measured parameters following aerobic exercise training (p &amp;amp;lt; 0.05).&amp;amp;nbsp;&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Conclusion:&amp;lt;/strong&amp;gt; Aerobic exercise is the most appropriate exercise to improve immune system and quality of life among elderly Alzheimer&amp;amp;rsquo;s.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Retrosternal goiter mimicking asthma: A diagnostic challenge</title>
		<pubDate>01/10/2020</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1017.php</link>
		<description>&amp;lt;h2&amp;gt;Editorial&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Asthma is a chronic respiratory disease characterized by chronic airway inflammation. Common manifestations of asthma include wheezing, chest tightness, cough, shortness of breath. Diagnosis of asthma requires clinical documentation of respiratory symptoms, exacerbation of symptoms following exposure to triggers, as well as demonstration of expiratory airflow obstruction. Wheeze is a continuous sound, lasting longer than 0.25 s that is produced by oscillation of opposing airway walls [1,2]. Wheezing, although a typical symptom of asthma, can also be caused by other diseases. Apart from asthma, wheezing can be due to extra-thoracic upper airway obstruction, intrathoracic upper airway obstruction, lower airway obstruction.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Biologic therapy in severe asthma: An update</title>
		<pubDate>08/28/2019</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1016.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Asthma is a chronic inflammatory disease of the airways characterized by airway inflammation, bronchial hyperresponsiveness, reversible airflow obstruction and recurrent symptoms. Patients often present with coughing, wheezing, dyspnea, and chest tightness, were they usually responds to the mainstay of treatment that relies on inhaled glucocorticoids (ICS), and long acting &amp;amp;beta;2 agonist (LABA), along with leukotriene. In around 20% of the patient&amp;amp;rsquo;s morbidity, mortality and cost of therapy increased because they fail to benefit from the existing gold standard therapy regimen. Both immunoglobulin-E (IgE), interlukin-5 (IL-5) had proven to play important major role in asthma pathogenesis. Over the past two decades biologic therapy that targeting IgE begins the era in treating severe asthma, and recently anti-IL-5, revealed major role in eosinophils maturation, activation, survival, and recruitment process of severe asthma. The different biologic therapy that is currently available in the market are supported by solid evidence from controlled randomized clinical trials, to guide the clinician on the type of patients that will benefit from the therapy, with an insight on the appropriate monitoring parameters and patient evaluation plans. This review was conducted by searching PubMed, EMBASE, and Google Scholar to identify peer-reviewed clinical trials, guidelines, and review articles published in English in the role of biologic therapy in severe asthma. The main aim from publishing this review is to summarize the current available evidence on the approved biologic therapy in treating patients with severe asthma.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Allergic Asthma and Sick building syndrome</title>
		<pubDate>01/11/2019</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1015.php</link>
		<description>&amp;lt;h2&amp;gt;Editorial&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Asthma is a complicated chronic disease of airway and airway inflammation, bronchoconstriction, cough, dyspnea and wheezing that are main symptoms of the asthma. Genetic, epigenetic and environmental agents are main factors in pathophysiology of the asthma. Direct and indirect healthcare costs and health-related quality of life in asthmatic patients require more and more attention. A main challenges of asthma control is environment and specially house and building [1].&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Pneumothorax, pneumomediastinum, subcutaneous emphysema: serious complications of asthma</title>
		<pubDate>12/21/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1014.php</link>
		<description>&amp;lt;h2&amp;gt;Editorial&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Bronchial asthma, is a quite common disease characterized by the chronic inflammation of the airways. It is due to the interaction of genetic with environmental factors. Currently, bronchial asthma is regarded as a public health problem, since its prevalence is constantly increasing worldwide. Common symptoms associated with asthma include repeated episodes of wheeze, dyspnoea, chest tightness and cough. Although commonly most asthmatic episodes are resolved with medical treatment, at times serious complications can deteriorate the clinical picture. Among these complications, the simultaneous spontaneous bilateral pneumothorax, the subcutaneous emphysema and the pneumomediastinum are life threatening complications.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>HIV-1 Immune evasion: The main obstacle toward a successful vaccine</title>
		<pubDate>12/19/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1013.php</link>
		<description>&amp;lt;h2&amp;gt;Mini Review&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;It is estimated that there are 36.9 million individuals living with HIV-1 from who 21.7 million patients receiving antiretroviral therapy (ART) [1,2]. ART has had a significant effect on the patients&amp;amp;rsquo; quality of life recently, however, its global coverage declines to 16-35% in low or middle income parts of Africa [3]. ART is unable to eliminate the virus from the infected individuals despite the fact of great impact on virus life cycle. There is no doubt that vaccination is considered as the most important medical strategy to prevent and suppress the infectious diseases. Nevertheless, there are many difficulties toward the cure or prevention of HIV-1 including the virus characteristics, lack of ideal animal model and funding [4-7].&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Diagnosis of Asthma in Childhood Age</title>
		<pubDate>09/13/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1012.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Background:&amp;lt;/strong&amp;gt; Asthma is the most common chronic respiratory disorder in childhood. Asthmatic attacks are described and classified according to the type of wheezing to Non &amp;amp;ndash;atopic and Atopic asthma (IgE mediated wheezing). The aim of this review is to determine the onset of clinical diagnosis in relation to clinical presentation of asthma in children and obstacles related to delay of Asthma diagnosis.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Methods:&amp;lt;/strong&amp;gt; This review highlights the results of studies done regarding clinical diagnosis in relation to clinical presentation and of asthma in children. An extensive search has been conducted for researches about asthma in children. This search based on the publications posted on the National Center for Biotechnology Information PubMed or by Google Scholar. Key words used for the research: Asthma, clinical diagnosis, children.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Results and Conclusion:&amp;lt;/strong&amp;gt; Diagnosing asthma in young children is difficult because children often cough and wheeze with colds and chest infections, but this is not necessarily asthma. Miss diagnosis of asthma in children occurs when physicians diagnose patients with asthma from the clinical diagnosis in the first attack without excluding other asthma mimickers which can be any other respiratory problem. There is over-diagnosis of asthma due to the symptoms which mimic other respiratory infections. First episodes of cough, runny nose and fever that happen in cold/flu season- fall/winter/early spring is likely not asthma. If the child has several more episodes of wheeze and cough, it is likely to be asthma. Since there is no diagnostic test available for children younger than 6 years of age, making a diagnosis in this age group is more difficult than in older children. Over the age of about 6 years it is possible for a child to have a spirometer test.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Interplay between asthma and gastroesophageal reflux disease: A controversial issue</title>
		<pubDate>03/05/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1011.php</link>
		<description>&amp;lt;h2&amp;gt;Editorial&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Gastroesophageal reflux disease (GERD) is a quite common disease caused by the reflux of gastric contents into the esophagus and manifested by heartburn and acid regurgitation. Apart from the esophageal manifestations, GERD is implicated in extraesophageal manifestations including pulmonary manifestations i.e. asthma, chronic cough, pneumonia, idiopathic pulmonary fibrosis, otolaryngological manifestations i.e. laryngitis, otitis, polyps, cancer of the larynx, chest pain [1,2]. The relationship between GERD and pulmonary manifestations is quite challenging and ongoing research efforts have focused on the elucidation of the pathogenesis of GERD induced asthma.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Role of Serum Magnesium levels in Asthmatic with children</title>
		<pubDate>02/23/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1010.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Objective: &amp;lt;/strong&amp;gt;To determine the association between serum magnesium level and asthma, by establishing the difference in serum magnesium level between children with asthma and controls.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Method:&amp;lt;/strong&amp;gt; Serum magnesium levels of 44 children with acute asthma and 44 controls of the age group of 6-16 years was determined and statistically compared. Lung function tests (FEV1%) were done and correlated with serum magnesium levels using Pearson&amp;amp;rsquo;s comparison coefficient.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Results: &amp;lt;/strong&amp;gt;The mean serum magnesium value of cases (1.9136&amp;amp;plusmn;0.44) is lower than the controls (2.0042&amp;amp;plusmn;0.26), with 32 cases showing a deficiency of serum magnesium. Pearson&amp;amp;rsquo;s correlation coefficient, reveals positive correlation between FEV1% with serum magnesium levels, r=0.819, P&amp;amp;lt;0.001.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Conclusions:&amp;lt;/strong&amp;gt; This study reveals that the serum magnesium levels, even if in normal range, are statistically lower amongst asthmatics. It also brings out the relationship between magnesium levels and lung function tests, showing an improvement in the latter with increase in the former.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Chemo-cytokines network is main target for control of Allergic asthma</title>
		<pubDate>01/25/2018</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1009.php</link>
		<description>&amp;lt;h2&amp;gt;Editorial&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Asthma is a chronic respiratory disease which characterized by recurrent airflow obstruction, wheezing, chest tightness and coughing. Management of allergic asthma especially in children, is main problem for industrial world. Immunological factors have critical role in pathogenesis of allergic asthma. Cytokines as major controller of immune system, are important in this reaction. Allergic asthma is a disease with symptoms: eosinophilic inflammation, mucus hyper secretion, airway obstruction, airways hyperresponsivness, IgE high level production, smooth muscle spasm. Cytokines have main and complicated role in pathophysiology of allergic asthma.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Cytokine Modulatory Effects of Sesamum Indicum Seeds Oil Ameliorate Mice with Experimental Autoimmune Encephalomyelitis</title>
		<pubDate>10/30/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1008.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Background:&amp;lt;/strong&amp;gt; Multiple sclerosis (MS) is an autoimmune disorder of the central nerve system (CNS), which affects the brain and spinal cord. Experimental autoimmune encephalomyelitis (EAE) is the most commonly applied experimental model for studying the MS. The aim of this study was to determine the effects of Sesamum indicum seeds oil on Experimental Autoimmune Encephalomyelitis (EAE) in mice.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Methods:&amp;lt;/strong&amp;gt; Sesame oil was administrated intraperitoneally three days before immunization. IFN-&amp;amp;gamma;, IL-10, IL-17 and TGF-&amp;amp;beta; levels and mRNA expression in supernatant of and within cultured mononuclear cells were assessed.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Results:&amp;lt;/strong&amp;gt; According to our results, sesame oil treated mice demonstrated significant disease severity reduction (P=0.01 and 0.001, respectively). Treated EAE mice also represented statistically significant delay in the onset of symptoms in comparison with control group. The average IFN-&amp;amp;gamma; levels and mRNA of sesame oil treated EAE mice were less than untreated EAE group. IL-10 and TGF-&amp;amp;beta; levels and mRNA did not differ significantly in sesame oil treated EAE mice in comparison to untreated EAE group. IL-17 levels and mRNA were also found to be decreased significantly in treated mice in comparison to untreated mice.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Conclusions:&amp;lt;/strong&amp;gt; Even thoughTH1 and TH17 cells through secretion of IFN-&amp;amp;gamma; and IL-17, respectively, are involved in the pathogenesis of multiple sclerosis and EAE, but IL-10 has been shown to exhibit suppressive effects on these disorders. It can be concluded that sesame oil is able to induce TH2 and TH17-related immune responses and suppress TH1 type in EAE.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Lack of applicability of the Enterocyte Chloride ion secretion paradigm to the Pathology of Cystic Fibrosis</title>
		<pubDate>10/23/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1007.php</link>
		<description>&amp;lt;h2&amp;gt;Summary&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;This review examines of the concept of a defective chloride channel in epithelial cells being a major cause of cystic fibrotic pathophysiology. The central concept of the defective chloride ion channel paradigm is that faulty CFTR protein or failed delivery of CFTR protein to the mucosal membrane of epithelial cells is the basis of cystic fibrosis. Defective placement or function of CFTR prevents hydration of bronchial mucus that is normally caused by epithelial cells; these are capable through chloride ion secretion of transporting fluid to the mucosal surface. This concept relies heavily on a paradigm taken from intestinal physiology-namely that the intestinal epithelial cell secretes chloride ion and fluid and that this has conferred heterozygote selective advantage in carriers of the cystic fibrosis gene. This present review examines the evidence for that hypothesis and assembles evidence from past studies that it is the smooth muscle cell that is of greater relevance. This review does not aim to provide an overview of current research into cystic fibrosis. The intention is to provide an overview of past research that led to the concept of a failure of epithelial cells to hydrate bronchial mucus because of compromised CFTR function. It is important to present all past evidence for aspects of the chloride secretion hypothesis and its associated heterozygote advantage concept so that the important evidential milestones can be re-assessed.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>The use of Allergoids and Adjuvants in Allergen Immunotherapy</title>
		<pubDate>09/20/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1006.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;small&amp;gt;Allergen immunotherapy (AIT) is the unique curative treatment to help allergic patients to get over their allergies. With a personalized approach, AIT is the best example of precision medicine. After a century of intensive studies and innovative discoveries, allergists have in their hands many tools to orchestrate the best strategy to re-educate the hypersensitive immune systems that decrease the quality of life of their patients. This review describes both the historical and the promising acquisitions in this field, focusing the biochemical and Bioengineering tools that render an allergen more suitable for a secure, convenient and effective immunotherapy.&amp;lt;/small&amp;gt;&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Inducible Laryngeal Obstruction/ Vocal Cord Dysfunction and the Role It Plays in Refractory Asthma</title>
		<pubDate>08/23/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1005.php</link>
		<description>&amp;lt;h2&amp;gt;Introduction&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Chronic asthma accounts for a significant amount of unscheduled office and emergency department (ED) visits. According to the latest World Health Organization statistics, asthma worldwide affects 300 million individuals and creates a substantial health burden by restricting the patient&amp;amp;rsquo;s lifetime activities. Data estimate that asthma causes a loss of disability-adjusted life years over 150,000/year [1].&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Prevalence of reported drug allergy and its impact on Beta lactam use with fi nancial and health implications</title>
		<pubDate>08/22/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1004.php</link>
		<description>&amp;lt;h2&amp;gt;Abstract&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Background: &amp;lt;/strong&amp;gt;While recognition and documentation of true drug allergy is critically important, most physicians acknowledge that its prevalence is likely overestimated, often on the basis of historical, sometimes anecdotal evidence. Correct or not, once applied, drug allergy labels may result in altered, potentially inferior therapy, increased costs and prolonged hospitalisation.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Objective:&amp;lt;/strong&amp;gt; Estimate the point prevalence, accuracy and symptomatology of self-reported drug allergy in a typical, large NHS Acute Trust adult inpatient population. In the subset with penicillin allergy (PA), estimate additional management costs from the use of alternative antibiotics and readmission rates in the previous 5 years.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Methods:&amp;lt;/strong&amp;gt; Data on self-reported drug allergies were extracted from 440 adult inpatient prescription charts over a 4 month period. Where penicillin allergy (PA) was reported, alternative antibiotic regimens were recorded and their additional costs calculated. Hospital electronic records were used to assess readmission rates of PA patients.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Results:&amp;lt;/strong&amp;gt; 194/440 inpatients (44.5%) reported at least one drug allergy. Antibiotic allergy was most commonly reported (51%), followed by analgesic (23%) and antiemetic (12%) allergy. PA accounted for 76% of reported antibiotic allergy. The commonest reported symptoms were cutaneous (42%) and gastrointestinal (18%). Where antibiotic therapy was required for patients with PA to manage acute infections, Ciprofloxacin, Clarithromycin, Teicoplanin, Clindamycin and Cefuroxime were the most commonly employed alternatives. Extrapolation of these figures to include the entire Trust inpatient population suggested that the use of alternative antibiotics in PA patients incurred additional annual expenditure of &amp;amp;pound;268,000. Further, 87% of PA patients had been admitted more than once in the preceding 5 years, with 74% requiring further courses of antibiotics during these admissions.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Conclusion: &amp;lt;/strong&amp;gt;Self-reported drug allergy, and in particular PA, is common in hospital inpatient populations and, in addition to the potentially unnecessary hazards to individual patients resulting from the use of alternative antibiotics, results in a considerable additional financial burden to the healthcare system. This problem could be eliminated by the provision of a nationwide and equitable tertiary Allergy service.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>The effects of early low dose exposures to the Environmental Estrogen Bisphenol A on the Development of Childhood Asthma</title>
		<pubDate>07/10/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1003.php</link>
		<description>&amp;lt;h2&amp;gt;SUMMARY&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;Exposure to environmental chemicals is a potential cause for the rapid increase in the prevalence of allergic asthma over the last few decades. The production of the environmental estrogen bisphenol A, the monomer of polycarbonate plastics, has increased rapidly over the last 50 years, such that bisphenol A is one of the most highly produced chemicals. It is detectable in the urine of the vast majority of the human population. While the relationship between the increase of bisphenol A in our environment and the prevalence of asthma does not prove a cause and effect relationship, it provides a strong rationale for experiments that have tested the hypothesis. Because of its small molecular size and hydrophobicity, bisphenol A is easily transferred from the mother to the fetus, via the placenta and in breast milk.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;We have reviewed all the publications available on medline on the human epidemiological studies of the early bisphenol A exposure on the development of allergic asthma and experimental studies using mouse model of the effects of early bisphenol A exposure on the development of asthma. There are eight human epidemiological studies and five mouse model studies currently published.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;The human studies suggest that bisphenol A exposure in early life enhances the likelihood of developing asthma on at least one of the study groups. The effects of early bisphenol A exposure were observed as an enhanced development of asthma before adolescent in the animal model.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Features of Interferon and Cytokine Status in Atopic Dermatitis</title>
		<pubDate>05/29/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1002.php</link>
		<description>&amp;lt;h2&amp;gt;ABSTRACT&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;The insufficiency of interferon production and the cytokine imbalance in patients with atopic dermatitis, especially in combination with persistent herpes virus infection, has been identified. The expediency of the use of interferon inducer Cycloferon in the treatment of chronic atopic dermatitis has been shown.&amp;lt;/p&amp;gt;</description>
	</item>
	<item>
		<title>Atopic Conjunctivitis in Children: Influence of Treatment with Topical Cyclosporin 0.05% in the Quality of Life</title>
		<pubDate>01/31/2017</pubDate>
		<link>https://www.theskygallerypattaya.com/haard/aaai-aid1001.php</link>
		<description>&amp;lt;h2&amp;gt;ABSTRACT&amp;lt;/h2&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Introduction: &amp;lt;/strong&amp;gt;Forty-six per cent children have allergic rhinoconjunctivitis (Allergologica 2005).&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Working hypothesis:&amp;lt;/strong&amp;gt; Ocular topical cyclosporine improves the quality of life for these patients.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Material, methods, design:&amp;lt;/strong&amp;gt; 2-year prospective study (2015-16), 40 patients with topical corticosteroids without improvement, followed 20 and 20 switched to corticosteroids cyclosporine 0.05%. Interview with Quality of Life Questionnaire in Children with rhinoconjunctivitis (PRQLQ) before and at the end of treatment. Mean age of 10.3 years with 60% male-40% female. Treatments were applied from January to March. There were 15 questions divided into two blocks. Children responded using a card with responses rated from zero (not bothered at all) to 6 (quite upset).&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Results: Before the 100% reported that, the itching was very bothersome. In the group of 40 children, 80% showed symptoms of epiphora and 60% showed symptoms of ocular inflammation. 100% complained of significant discomfort in rubbing their eyes, 30% did not like to take medications. Headaches affected 20%. 100% stated that they cannot play normally. 80% showed decreased concentration in class.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Continuing with corticosteroids did not show statistically significant changes.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;Patients with cyclosporine improved the results by 3 points, with decreased itching, tearing, swelling, pain, eye rubbing, medication and headaches. In the 2nd questionnaire there was limited variation in the results related to fatigue, malaise, and irritability but with substantially improved balance of sleep, insomnia and concentration at school.&amp;lt;/p&amp;gt;

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Conclusion:&amp;amp;nbsp;&amp;lt;/strong&amp;gt;Cyclosporine A is a cyclic polypeptide calcineurin inhibitor developed from the fungus Tolypocladium inflatum. The first dilution was 2% but it is currently used at a dilution of 0.05% and recent publications suggest nanosuspensions. Our study showed improvement in parameters related to symptoms, especially itching and lower improvement of psychological aspects, this achieves a better quality of life for children and more willingness to adhere to the treatment.&amp;lt;/p&amp;gt;</description>
	</item>
</channel>
</rss>